Skip to site menu Skip to page content
23 Dec 2024

Sequana shares surge after FDA approval for alfapump

The US Food and Drug Administration (FDA) has approved Sequana Medical’s alfapump for the treatment of recurrent or refractory ascites due to liver cirrhosis. The agency’s greenlight makes Sequana’s product…

[ajax_load_more post_type="post" taxonomy="category" taxonomy_terms="company-news, contract-news, deal-news, industry-news, news" taxonomy_operator="IN" images_loaded="true" posts_per_page="20" offset="7" pause="true" scroll="false" button_label="Load More Stories"]